IMMUNOTECH BIOPHARM
Similar Organizations
Gemin X Biotechnologies
Gemin X Biotechnologies Inc. operates as a biopharmaceutical company .
Jenrin Discovery
Jenrin Discovery is a biopharmaceutical Company.
Stock Details
More informations about "Immunotech Biopharm"
Immunotech Biopharm Ltd (6978.HK) - Yahoo Finance
See the company profile for Immunotech Biopharm Ltd (6978.HK) including business summary, industry/sector information, number of employees, business summary, corporate governance, …See details»
Immunotech Biopharm - Funding, Financials, Valuation & Investors
Organization. Immunotech Biopharm . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies ... IPO & Stock Price. Edit IPO & Stock Price …See details»
Largest in the World! China's First Cellular Drug ... - Beijing
Beijing Immunotech Biopharm Ltd. (Immunotech Biopharm) is China's first innovative biotech enterprise engaged in the R&D of cellular immunotherapy products. As a project under …See details»
Immunotech Biopharm Company Description - Stock Analysis
Oct 22, 2024 Immunotech Biopharm Ltd, a cellular immunotherapy biopharmaceutical company, focuses on the research, development, and commercialization of T cell immunotherapy …See details»
Immunotech Biopharm Company Profile - Craft
Oct 29, 2024 Immunotech Biopharm. Financials. Summary Financials. Gross profit (FY, 2023)¥7.5M Net income (FY, 2023)(¥335.5M) Cash (FY, 2023)¥52.2M EBIT (FY, …See details»
Körber signs strategic agreement with Chinese …
Immunotech Biopharm Ltd. is an innovative technology enterprise specializing in the research and development of immunotherapeutic drugs. It has been recognized as a China national high-tech enterprise and owns internationally …See details»
Immunotech Biopharm Ltd, 6978:HKG summary - FT.com
Nov 22, 2024 Immunotech Biopharm Ltd is a China-based investment holding company mainly engaged in the research and development, manufacturing and commercialization of immune …See details»
Economic Watch: Immunotech Biopharm highlights China's push …
Aug 16, 2024 Immunotech Biopharm's story is a testament to the broader trends shaping China's industrial landscape. Driven by the country's unwavering focus on innovation, the …See details»
Immunotech Biopharm Receives an Approval of the Investigational …
Feb 19, 2024 Immunotech Biopharm Ltd is a China-based investment holding company mainly engaged in the research and development, manufacturing and commercialization of immune …See details»
INTERIM REPORT - HKEXnews
Immunotech Biopharm Ltd 4 Interim Report 2021 Financial and Operational Data Highlights HIGHLIGHTS FOR THE SIX MONTHS ENDED 30 JUNE 2021 For the six months ended 30 …See details»
Immunotech Biopharm eyes automation to cut cell therapy costs
Jul 10, 2020 Immunotech Biopharm has the capacity to produce treatments for about 2,000 patients per year and hopes the completion of a new plant in Beijing will enable it to expand to …See details»
Immunotech Biopharm Ltd (6978.HK) - Yahoo Finance
Immunotech Biopharm Ltd was founded in 2006 and is headquartered in Beijing, the People's Republic of China. www.eaal.net . 202. Full Time Employees. December 31. Fiscal Year Ends. …See details»
Chinese biotech firm Immunotech deploys IPO cash to bet on next ...
Jul 13, 2020 Immunotech Biopharm expects to collect results from its clinical trials on liver-cancer patients next year and aims to win marketing approval for its technology in 2022, CEO …See details»
Immunotech CEO: IPO shines light on China’s innovation in
Jul 14, 2020 BEIJING – Beijing-based Immunotech Biopharm Ltd. made a strong debut as the first pre-revenue cellular immunotherapy firm to trade on the Hong Kong Stock Exchange …See details»
AIM ImmunoTech shareholders elect new directors amid proxy battle
AIM ImmunoTech Inc., a company specializing in biological products, concluded its 2024 Annual Meeting of Stockholders on December 17. ... The company, previously known as Hemispherx …See details»
Immunotech Biopharm Ltd Announces First Patient Enrolled in the …
Jan 3, 2024 Immunotech Biopharm Ltd. announce that the Company has completed the first patient enrolment for its Phase II clinical trial for CAR-T-19 injection ("CAR-T-19 Injection") in …See details»
Immunotech Biopharm sets price range for Hong Kong IPO
Jun 29, 2020 Immunotech Biopharm Ltd. priced its Hong Kong IPO of 100 million shares at between HK$10.50 and HK$11.00 apiece. The Chinese cancer therapy developer will raise …See details»
Gli azionisti di AIM ImmunoTech eleggono nuovi amministratori in …
1 hour ago AIM ImmunoTech Inc., un'azienda specializzata in prodotti biologici, ha concluso la sua Assemblea Annuale degli Azionisti 2024 il 17 dicembre. L'assemblea, tenutasi a Ocala, in …See details»
Immunotech Biopharm Ltd Announces CAR-T-19 Injection …
Dec 11, 2024 Immunotech Biopharm Ltd. announced that the Group's product, CAR-T-19 Injection, which is an anti-CD19 single-chain antibody chimeric antigen receptor T-cell …See details»
Los accionistas de AIM ImmunoTech eligen nuevos directores en …
1 hour ago Los accionistas de AIM ImmunoTech eligen nuevos directores en medio de una batalla de representación ... La empresa, anteriormente conocida como Hemispherx …See details»